Business · 1 sources covering this

Germany's Merck boosts life sciences business with $11 billion Bio-Techne deal

Merck KGaA has agreed to acquire biotech firm Bio-Techne for $11.3 billion, the ⁠German ‌science and healthcare ⁠firm said in a statement on Thursday.

Share:X WhatsApp Reddit Facebook LinkedIn Open ↗

Coverage spectrum

0 L · 0 C · 1 R

How 1 sources are covering this

CNBCLean R·48m ago
Germany's Merck boosts life sciences business with $11 billion Bio-Techne deal
Merck KGaA has agreed to acquire biotech firm Bio-Techne for $11.3 billion, the ⁠German ‌science and healthcare ⁠firm said in a statement on Thursday.
Read at CNBC →

Embed this bias spectrum on your site

Paste this iframe wherever you'd like the widget to appear. Resizes responsively; no JS required.

<iframe
  src="https://statesidedaily.com/embed/cluster/cc59e71cb93d98d66526c6ee64522f2aa4089257"
  width="100%" height="320"
  style="border:0;max-width:680px"
  loading="lazy"
  title="Germany's Merck boosts life sciences business with $11 billion Bio-Techne deal"></iframe>

Germany's Merck boosts life sciences business with $11 billion Bio-Techne deal

How 1 sources are covering this

Germany's Merck boosts life sciences business with $11 billion Bio-Techne deal

More from Business

Nasdaq futures rally as Micron surges after earnings; Wall Street awaits key inflation reading: Live updates

Larry Sanger, a Wikipedia Founder, Is Barred From Editing on the Site

Ryanair 'reluctantly' agrees to let parents sit with children for free

Bitcoin is having a tough year. Traders are betting it's going to get worse

Reader

Trust & legal

Across the network